Fundraising Fox

Acer Therapeutics

Cambridge, US · Founded 2013 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

Acer Therapeutics was founded in 2013 by Christopher Schelling.

CS
Christopher SchellingFounder
HS
Harry S. PalminExecutive

Board

CL
Cynthia LavoieBoard director

Investors · 1

TVM CapitalreportedMunich · $1.1M – $16.2Mvia Hubert Birner · board

Reported raises · per SEC filings

Form D private placements

$29M disclosed across 4 rounds · 2015–2017

▶$15.7MraisedOct 2017 · 10 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert SteinerExecutive Officer
  • Christopher SchellingExecutive Officer, Director
  • Harry S. PalminExecutive Officer
  • John DunnDirector
  • Hubert BirnerDirector
  • Luc MarengereDirector
  • Stephen AselageDirector
Offering amount
$15.7M
Amount sold
$15.7M
Sales commissions
$1.1M
Finders' fees
$67.5K
Proceeds to insiders
$948K
Placement agents
Piper Jaffray & Co.
First sale
Sep 2017
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.1MraisedApr 2017 · 4 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • John DunnDirector
  • Christopher SchellingExecutive Officer, Director, Promoter
  • Luc MarengereDirector
  • Stephen AselageDirector
  • Harry PalminPromoter
Offering amount
$5.5M
Amount sold
$3.1M
Proceeds to insiders
$419K
First sale
Mar 2017
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.1MraisedMay 2016 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • John DunnDirector
  • Harry S. PalminPromoter
  • Christopher SchellingExecutive Officer, Director, Promoter
  • Stephen AselageDirector
  • Cynthia LavoieDirector
  • Luc MarengereDirector
Offering amount
$8.1M
Amount sold
$8.1M
Proceeds to insiders
$740K
First sale
Apr 2016
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.1MraisedApr 2015 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Cynthia LavoieDirector
  • Harry S. PalminExecutive Officer, Director, Promoter
  • Christopher SchellingExecutive Officer, Director, Promoter
Offering amount
$2.1M
Amount sold
$2.1M
Proceeds to insiders
$290K
First sale
Mar 2015
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded Acer Therapeutics?
Acer Therapeutics was founded by Christopher Schelling in 2013.
Who are Acer Therapeutics's investors?
Acer Therapeutics's investors include TVM Capital.
How much funding has Acer Therapeutics raised?
Acer Therapeutics has disclosed $29M raised across 4 rounds.
Where is Acer Therapeutics headquartered?
Acer Therapeutics is headquartered in Cambridge, US.